Literature DB >> 28710089

Endothelium-Neutrophil Communication via B1-Kinin Receptor-Bearing Microvesicles in Vasculitis.

Pierre-Louis Tharaux1, Neeraj Dhaun2.   

Abstract

Entities:  

Keywords:  Henoch-Schonlein Purpura; Immunology and pathology; bradykinin; endothelium; microvesicles; vasculitis

Mesh：

Substances：

Year:  2017        PMID： 28710089      PMCID： PMC5533246          DOI： 10.1681/ASN.2017030300

Source DB:  PubMed          Journal:  J Am Soc Nephrol        ISSN： 1046-6673            Impact factor:   10.121


× No keyword cloud information.
  18 in total

1.  Delayed blockade of the kinin B1 receptor reduces renal inflammation and fibrosis in obstructive nephropathy.

Authors:  J Klein; J Gonzalez; J Duchene; L Esposito; J P Pradère; E Neau; C Delage; D Calise; A Ahluwalia; P Carayon; J B Pesquero; M Bader; J P Schanstra; J L Bascands
Journal:  FASEB J       Date:  2008-09-22       Impact factor: 5.191

Review 2.  Microvesicles as cell-cell messengers in cardiovascular diseases.

Authors:  Xavier Loyer; Anne-Clémence Vion; Alain Tedgui; Chantal M Boulanger
Journal:  Circ Res       Date:  2014-01-17       Impact factor: 17.367

3.  The B1-agonist [des-Arg10]-kallidin activates transcription factor NF-kappaB and induces homologous upregulation of the bradykinin B1-receptor in cultured human lung fibroblasts.

Authors:  J P Schanstra; E Bataillé; M E Marin Castaño; Y Barascud; C Hirtz; J B Pesquero; C Pecher; F Gauthier; J P Girolami; J L Bascands
Journal:  J Clin Invest       Date:  1998-05-15       Impact factor: 14.808

4.  C1-Inhibitor Decreases the Release of Vasculitis-Like Chemotactic Endothelial Microvesicles.

Authors:  Maria Mossberg; Anne-Lie Ståhl; Robin Kahn; Ann-Charlotte Kristoffersson; Ramesh Tati; Caroline Heijl; Mårten Segelmark; L M Fredrik Leeb-Lundberg; Diana Karpman
Journal:  J Am Soc Nephrol       Date:  2017-03-13       Impact factor: 10.121

Review 5.  The plasma bradykinin-forming pathways and its interrelationships with complement.

Authors:  Allen P Kaplan; Berhane Ghebrehiwet
Journal:  Mol Immunol       Date:  2010-08       Impact factor: 4.407

6.  B1 bradykinin receptors and carboxypeptidase M are both upregulated in the aorta of pigs after LPS infusion.

Authors:  E Schremmer-Danninger; A Offner; M Siebeck; A A Roscher
Journal:  Biochem Biophys Res Commun       Date:  1998-02-04       Impact factor: 3.575

7.  Neutrophil-derived proteinase 3 induces kallikrein-independent release of a novel vasoactive kinin.

Authors:  Robin Kahn; Thomas Hellmark; L M Fredrik Leeb-Lundberg; Nasrin Akbari; Mihail Todiras; Tor Olofsson; Jörgen Wieslander; Anders Christensson; Kerstin Westman; Michael Bader; Werner Müller-Esterl; Diana Karpman
Journal:  J Immunol       Date:  2009-06-15       Impact factor: 5.422

8.  Bradykinin B1 and B2 receptors both have protective roles in renal ischemia/reperfusion injury.

Authors:  Masao Kakoki; Robert W McGarrah; Hyung-Suk Kim; Oliver Smithies
Journal:  Proc Natl Acad Sci U S A       Date:  2007-04-23       Impact factor: 11.205

9.  Genetic variants in ANCA-associated vasculitis: a meta-analysis.

Authors:  Chinar Rahmattulla; Antien L Mooyaart; Daphne van Hooven; Jan W Schoones; Jan A Bruijn; Olaf M Dekkers; Ingeborg M Bajema
Journal:  Ann Rheum Dis       Date:  2015-10-06       Impact factor: 19.103

10.  Wegener's granulomatosis: anti-proteinase 3 antibodies are potent inductors of human endothelial cell signaling and leakage response.

Authors:  U Sibelius; K Hattar; A Schenkel; T Noll; E Csernok; W L Gross; W J Mayet; H M Piper; W Seeger; F Grimminger
Journal:  J Exp Med       Date:  1998-02-16       Impact factor: 14.307
View more
  1 in total

1.  Impaired Kallikrein-Kinin System in COVID-19 Patients' Severity.

Authors:  Enrique Alfaro; Elena Díaz-García; Sara García-Tovar; Ester Zamarrón; Alberto Mangas; Raúl Galera; Kapil Nanwani-Nanwani; Rebeca Pérez-de-Diego; Eduardo López-Collazo; Francisco García-Río; Carolina Cubillos-Zapata
Journal:  Front Immunol       Date:  2022-06-22       Impact factor: 8.786
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.